U.S. FDA headquarters building and sign.![](https://eu-images.contentstack.com/v3/assets/blt14ac89070d5e4751/bltc3c8e44f17eb308a/651ade90b64ed75c6a06626b/FDA_20headquarters.png?width=700&auto=webp&quality=80&disable=upscale)
Regulatory & Quality![](https://eu-images.contentstack.com/v3/assets/blt14ac89070d5e4751/bltc3c8e44f17eb308a/651ade90b64ed75c6a06626b/FDA_20headquarters.png?width=700&auto=webp&quality=80&disable=upscale)
FDA Finds iRhythm out of Sync with RegulationsFDA Finds iRhythm out of Sync with Regulations
The heart monitoring device maker is facing an FDA warning letter on the heels of a DOJ subpoena.
Sign up for the QMED & MD+DI Daily newsletter.